Medicago's H5N1 VLP vaccine provides protection against multiple strains of avian flu
Cross-protection established against deadly Vietnam strain
25-Mar-2008 -
Medicago Inc. announced that its H5N1 Avian Influenza VLP vaccine, made from the Indonesian strain, provided 100% protection in mice against a lethal challenge with live H5N1 viruses of the Vietnam strain. Including these results, the Company has now established that its lead H5N1 VLP vaccine has ...
avian influenza
biochemistry
Medicago
+4